Topoisomerase II Inhibitors and Poisons, and the Influence of Cell Cycle Checkpoints

E-ISSN： 1875-533x|24|15|1504-1519

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.15, 2017-06, pp. : 1504-1519

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Developments of DNA Poisons - Human DNA Topoisomerase II Inhibitors - as Anticancer Agents

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2474-2488

Bentham Science Publishers

Access to resources Recommend Favorite

Dual Topoisomerase I/II Poisons as Anticancer Drugs

By Denny W.A.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1845-1852

Informa Healthcare

Access to resources Recommend Favorite

Toxicity of the topoisomerase II inhibitors

By Seiter Karen

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 219-234

Informa Healthcare

Access to resources Recommend Favorite

Tumor cell resistance to DNA topoisomerase II inhibitors: new developments

By Beck W.T. Morgan S.E. Mo Y-Y. Bhat U.G.

Drug Resistance Updates, Vol. 2, Iss. 6, 1999-12 ,pp. : 382-389

Academic Press

Access to resources Recommend Favorite

A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons

By Capranico G. Binaschi M. Borgnetto M.E. Zunino F. Palumbo M.

Trends in Pharmacological Sciences, Vol. 18, Iss. 9, 1997-10 ,pp. : 323-329

Elsevier

Access to resources Recommend Favorite